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Abstract
Background: Apoptosis plays a critical role during neuronal development and disease. Developing sympathetic
neurons depend on nerve growth factor (NGF) for survival during the late embryonic and early postnatal period
and die by apoptosis in its absence. The proapoptotic BH3-only protein Bim increases in level after NGF withdrawal
and is required for NGF withdrawal-induced death. The regulation of Bim expression in neurons is complex and
this study describes a new mechanism by which an NGF-activated signalling pathway regulates bim gene
expression in sympathetic neurons.
Results: We report that U0126, an inhibitor of the prosurvival MEK-ERK pathway, increases bim mRNA levels in
sympathetic neurons in the presence of NGF. We find that this effect is independent of PI3-K-Akt and JNK-c-Jun
signalling and is not mediated by the promoter, first exon or first intron of the bim gene. By performing 3’ RACE
and microinjection experiments with a new bim-LUC+3’UTR reporter construct, we show that U0126 increases bim
expression via the bim 3’ UTR. We demonstrate that this effect does not involve a change in bim mRNA stability
and by using PD184352, a specific MEK1/2-ERK1/2 inhibitor, we show that this mechanism involves the MEK1/2-
ERK1/2 pathway. Finally, we demonstrate that inhibition of MEK/ERK signalling independently reduces cell survival
in NGF-treated sympathetic neurons.
Conclusions: These results suggest that in sympathetic neurons, MEK-ERK signalling negatively regulates bim
expression via the 3’ UTR and that this regulation is likely to be at the level of transcription. This data provides
further insight into the different mechanisms by which survival signalling pathways regulate bim expression in
neurons.
Background
In mammalian cells, two major apoptotic pathways have
been described: the extrinsic (death receptor) pathway
and the intrinsic (mitochondrial) pathway. The permea-
bilisation of the mitochondrial outer membrane is a key
step in the intrinsic pathway, which proceeds following
complex interactions between proapoptotic and antia-
poptotic members of the Bcl-2 superfamily of cell death
regulators. The BH3-only Bcl-2 family protein Bim is an
important initiator and regulator of the intrinsic path-
way since Bim can interact with both the antiapoptotic
Bcl-2 proteins and the multidomain proapoptotic effec-
tor proteins Bax and Bak [1,2].
Bim is a critical mediator of apoptosis in many cell
types including NGF-dependent sympathetic neurons. In
these cells bim RNA and Bim protein levels increase
rapidly following NGF deprivation and peak at around
16 hours later [3,4]. Overexpression of BimEL in sympa-
thetic neurons is sufficient to induce the release of cyto-
chrome c and apoptosis in the presence of NGF and
sympathetic and sensory neurons isolated from bim-/-
knockout mice are significantly protected from trophic
factor withdrawal-induced death [3-5].
The binding of NGF to the TrkA tyrosine kinase
receptor on the surface of sympathetic neurons activates
the PI3-K-Akt and Raf-MEK-ERK signalling pathways
which can both inhibit apoptosis and promote cell
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survival [6,7]. It is now evident that a number of regula-
tory mechanisms exist to prevent the inappropriate
expression of bim in neurons. Three transcriptional
pathways have been described, each of which targets ele-
ments within the bim promoter. Firstly, bim transcrip-
tion is repressed by PI3-K-Akt signalling: active Akt
phosphorylates FOXO3a, which is sequestered in the
cytoplasm by 14-3-3 protein and following NGF with-
drawal FOXO3a translocates into the nucleus of sympa-
thetic neurons and activates bim expression via two
conserved FOXO binding sites [8,9]. Secondly, bim is
activated by a Cdk4-E2F-Myb pathway following NGF
withdrawal in neuronally differentiated PC12 cells and
this requires Myb binding sites in the bim promoter
[10]. Thirdly, MLK-JNK-c-Jun signalling appears to be
critical for bim upregulation in sympathetic neurons: the
overexpression of a dominant negative c-Jun protein
reduces the increase in bim mRNA and protein level
that occurs after NGF withdrawal [3] and the junAA
knock-in mutation, which eliminates the two major JNK
phosphorylation sites in c-Jun, reduces the increase in
Bim protein level after NGF withdrawal [11].
Post-translational mechanisms that regulate the activ-
ity of the Bim protein in neuronal cells have also been
described. BimEL is a target of the RAF-MEK-ERK sig-
nalling pathway, which delivers important survival sig-
nals in many different cell types. In neuronally
differentiated PC12 cells maintained in the presence of
NGF, BimEL is phosphorylated by ERK [12], and studies
with serum-treated fibroblasts have demonstrated that
BimEL contains an ERK1/2 docking site and ERK phos-
phorylation sites via which the MEK1/2-ERK1/2 path-
way promotes the phosphorylation of BimEL leading to
its ubiquitylation and degradation via the proteasome
[13-17]. Furthermore, the ERK1/2-dependent phosphor-
ylation of BimEL leads to the dissociation of BimEL from
complexes with the antiapoptotic Mcl-1 and Bcl-xL pro-
teins and also the proapoptotic Bax protein [17,18].
However, it is not known whether the MEK-ERK
pathway controls bim expression in neurons at a step
prior to the phosphorylation of BimEL. Here, we have
investigated this using NGF-dependent developing sym-
pathetic neurons. We show that in the presence of
NGF, MEK-ERK signalling reduces bim mRNA levels
and that this is a transcriptional mechanism mediated
through the bim 3’ UTR.
Results
The MEK-ERK pathway negatively regulates bim mRNA
expression independently of the PI3-K-Akt and the
JNK-c-Jun pathways in sympathetic neurons
To investigate whether the MEK-ERK signalling pathway
regulates the steady state level of bim mRNA in sympa-
thetic neurons cultured in the presence of NGF, we
used a well characterised MEK inhibitor, U0126, to
reduce MEK and therefore ERK activity. To confirm
that phospho-ERK1/2 levels are reduced when sympa-
thetic neurons are treated with U0126, immunoblots
were performed with extracts from sympathetic neurons
either maintained in NGF-containing medium or treated
with increasing concentrations of U0126 in the presence
of NGF (Figure 1A). Treatment of sympathetic neurons
with U0126 at 10 μM strongly reduced the phosphoryla-
tion of ERK1 and ERK2, whereas total ERK protein
levels were not altered (Figure 1A).
Next, we verified that Bim protein levels are upregu-
lated in sympathetic neurons following treatment with
U0126 or with the PI3-K inhibitor LY294002 (Figure 1B).
Immunoblots were performed using extracts from sym-
pathetic neurons either maintained in NGF-containing
medium, withdrawn from NGF for 16 hours or treated
with either LY294002 (50 μM) or U0126 (10 μM) in the
presence of NGF for 16 hours. Bim protein levels
increased strongly following NGF withdrawal and follow-
ing treatment with U0126 or with LY294002, whereas
a-Tubulin protein levels were not altered (Figure 1B).
We then confirmed that U0126 inhibits MEK-ERK sig-
nalling without affecting the two major signalling path-
ways known to be involved in Bim regulation, the PI3-K-
Akt pathway and the JNK-c-Jun pathway (Figure 1C, D).
Immunoblots were performed with extracts from sympa-
thetic neurons either maintained in the presence of NGF,
withdrawn from NGF for 16 hours or treated with U0126
(10 μM) for 16 hours in the presence of NGF. As
expected, we found that the level of phosphorylation of
Akt at Ser 473 is high when neurons are maintained in
the presence of NGF and falls following NGF withdrawal
[8] (Figure 1C) and that c-Jun phosphorylation at serine
63 increases following NGF withdrawal [19] (Figure 1D).
Importantly, treatment with U0126 did not affect phos-
pho-Akt or phospho-c-Jun levels (Figure 1C, D), thereby
confirming that the PI3-K-Akt and the JNK-c-Jun path-
ways are independent of MEK-ERK signalling in sympa-
thetic neurons.
To investigate whether the MEK-ERK pathway regulates
bim mRNA levels, we carried out q-PCR with cDNA
prepared from sympathetic neurons maintained in NGF-
containing medium, withdrawn from NGF for 16 hours,
or treated with either LY294002 (50 μM) or U0126
(10 μM) in the presence of NGF for 16 hours (Figure 1E).
The level of bim mRNA was analysed relative to the level
of the transcripts for the house-keeping genes Hprt1 and
Gapdh. Bim mRNA levels relative to Hprt1 are shown
(Figure 1E), since both house-keeping genes behaved in a
similar way. After NGF withdrawal, the level of bim
mRNA increased by 5 fold and upon treatment with
LY294002 it increased by 4.2 fold, as described previously
[8]. Interestingly, when the cells were treated with U0126,
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there was also a significant (3.4 fold) increase in the level
of bim mRNA. This data indicates that in the presence of
NGF the MEK-ERK pathway negatively regulates bim
mRNA expression in sympathetic neurons.
The MEK-ERK pathway negatively regulates bim mRNA
expression in sympathetic neurons via regulatory elements
outside of the bim promoter, exon 1 and first intron
To determine the mechanism by which the MEK-ERK
pathway negatively regulates bim expression in sympa-
thetic neurons we investigated which region of the bim
gene mediates this effect. Initially, sympathetic neurons
were microinjected with a bim-LUC reporter construct
to determine whether there are any MEK-ERK-respon-
sive elements within the 5.2 kb fragment of bim that is
cloned in bim-LUC. This construct contains 2.5 kb of the
bim promoter, the non-coding exon 1 and the 2.5 kb first
intron [8]. Following injection, the cells were either main-
tained in medium containing NGF, withdrawn from
NGF, or treated with either LY294002 (50 μM) or U0126
(10 μM) in the presence of NGF, and luciferase activity
was determined after 16 hours (Figure 2). Following NGF
Figure 1 The MEK-ERK pathway negatively regulates bim mRNA expression in sympathetic neurons. (A) Effect of U0126 on
phosphorylation of ERK1/2 in sympathetic neurons. Immunoblots were performed with whole cell extracts from sympathetic neurons
maintained in the presence of NGF and left untreated or treated with U0126 at 5, 10, 20 or 40 μM for 16 hours. Antibodies to detect total ERK1/
2 (Cell Signaling #9102) and phospho-ERK1/2 (Cell Signaling #9101) were used. (B) Effect of U0126 or LY294002 on Bim protein levels in
sympathetic neurons. Immunoblots were performed with whole cell extracts from sympathetic neurons maintained in the presence of NGF,
withdrawn from NGF for 16 hours, or treated with 50 μM LY294002, or with 10 μM U0126, for 16 hours in the presence of NGF. Antibodies to
detect Bim (Chemicon AB17003) and a-Tubulin (AbD Serotec MCA77G) were used. (C) U0126 does not alter Akt phosphorylation in sympathetic
neurons. Immunoblots were performed with whole cell extracts from sympathetic neurons maintained in the presence of NGF, treated with 10
μM U0126 for 16 hours in the presence of NGF, or withdrawn from NGF for 16 hours. Antibodies to detect total Akt (Cell Signaling #9272),
phospho-Akt (Cell Signaling #9271) and total ERK1/2 (Cell Signaling #9102) were used. (D) U0126 does not alter c-Jun phosphorylation in
sympathetic neurons. Cells were treated as in (C) and antibodies to detect total c-Jun (BD Biosciences #610327), phospho-c-Jun (Santa Cruz sc-
822) and total ERK1/2 (Cell Signaling #9102) were used. (E) Total RNA was prepared from sympathetic neurons treated as in (B) and bim mRNA
levels were analysed by q-PCR relative to the level of the mRNA encoded by the house-keeping gene Hprt1. The data is presented as the mean
± S.E., n = 3. Endogenous bim mRNA levels increased significantly following NGF withdrawal and treatment with LY294002, respectively (p =
0.015 and p = 0.014). Treatment with U0126 also induced a significant increase in the level of bim mRNA (p = 0.0003).
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withdrawal, or treatment with LY294002 [8], bim-LUC
was activated significantly (Figure 2). However, when the
cells were treated with U0126 there was no increase in
the activity of bim-LUC (Figure 2). This suggests that
there are no MEK-ERK-responsive elements within the
first 2.5 kb of the bim promoter, exon 1 or the first
intron.
The bim 3’ UTR contains elements that are responsive to
NGF withdrawal
Our results indicate that the region that mediates the
regulation of bim by the MEK-ERK pathway is not
located at the 5’ end of the bim gene. Therefore we
hypothesised that the bim 3’ UTR may contain the target
region, since the 3’ UTR of a gene often contains a num-
ber of regulatory motifs that are important for modulat-
ing gene expression. These can include transcriptional
enhancers or silencers, or sequences in the 3’ UTR of the
mRNA that are targeted by microRNAs or bound by
RNA binding proteins that regulate mRNA stability. Initi-
ally, we mapped the 3’ end of the rat bim mRNA by 3’
RACE. This indicated that the 3’ UTR is 4.2 kb long. We
then cloned the entire bim 3’ UTR into our bim-LUC
reporter construct, downstream of the luciferase gene, to
generate the bim-LUC+3’UTR construct (Figure 3A). To
compare the bim-LUC+3’UTR construct to bim-LUC,
sympathetic neurons were microinjected with equimolar
concentrations of bim-LUC+3’UTR or bim-LUC, and
either maintained in the presence of NGF or withdrawn
from NGF for 16 hours, after which time luciferase activ-
ity was determined (Figure 3B, C). We found that the
addition of the 3’ UTR greatly reduced the basal level of
the bim-LUC construct in the presence of NGF, suggest-
ing that the bim 3’ UTR contains sequences that reduce
luciferase activity at the level of transcription, RNA stabi-
lity or translation. Critically, addition of the 3’ UTR to
the bim-LUC reporter significantly increased its induc-
tion from 1.8 fold to 3 fold, following NGF withdrawal
(Figure 3C). This demonstrates that the bim 3’ UTR con-
tains elements that are responsive to NGF withdrawal. It
is likely that the new bim-LUC+3’UTR construct is more
representative of the endogenous bim gene than the ori-
ginal bim-LUC construct since endogenous bim mRNA
levels increase by around 5 fold after NGF withdrawal
(Figure 1E).
The bim 3’UTR is a target of the MEK-ERK pathway in
sympathetic neurons
To ascertain whether the bim 3’ UTR is a target of the
MEK-ERK pathway, sympathetic neurons were microin-
jected with bim-LUC+3’UTR or bim-LUC and the cells
were either maintained in medium containing NGF or
treated with U0126 (10 μM) in the presence of NGF.
After 16 hours, relative luciferase activity was deter-
mined (Figure 3D, E). As demonstrated previously, inhi-
bition of the MEK-ERK pathway with U0126 did not
activate the bim-LUC construct (Figure 3D, E). How-
ever, when bim-LUC+3’UTR was treated with U0126
there was a significant activation of the reporter to 2.5
fold (Figure 3D, E). This suggests that the regulation of
bim mRNA level via the MEK-ERK-pathway is mediated
by the 3’ UTR region of the bim gene.
Figure 2 The MEK-ERK pathway negatively regulates bim
expression via regulatory elements outside of the bim
promoter, exon 1 and intron 1. Sympathetic neurons were
microinjected with the bim-LUC construct (10 ng/μl) along with
pRL-TK (5 ng/μl) to control for injection efficiency. The cells were
either maintained in medium containing NGF, withdrawn from NGF,
treated with LY294002 at 50 μM, or with U0126 at 10 μM, in the
presence of NGF. After 16 hours, luciferase activity was measured.
Relative luciferase activity was determined by normalisation of Firefly
luciferase activity to Renilla luciferase activity (pRL-TK refers to Renilla
luciferase under the control of the thymidine kinase promoter). The
data is presented as the mean ± S.E., n = 4. Bim-LUC is activated
significantly following NGF withdrawal or after treatment with
LY294002, respectively (p = 0.003 and p = 0.001). However,
treatment with U0126 does not activate the bim-LUC construct.
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Figure 3 The MEK-ERK pathway negatively regulates bim expression through the bim 3’UTR. (A) Structure of the bim-LUC and bim-LUC
+3’UTR reporter constructs. Bim-LUC+3’UTR was constructed by cloning and inserting the 4.2 kb rat bim 3’UTR into the bim-LUC construct [8],
upstream of the SV40 late poly (A) signal and downstream of the luciferase reporter gene. The locations of two conserved FOXO binding sites and
an inverted CCAAT box (ICB) are shown. (B) Sympathetic neurons were microinjected with bim-LUC at 10 ng/μl or bim-LUC+3’UTR at 14 ng/μl,
along with pRL-TK to control for injection efficiency (5 ng/μl). The cells were maintained in medium containing NGF (+NGF) or withdrawn from
NGF (-NGF) for 16 hours, after which time luciferase activity was measured. Relative luciferase activity was determined by normalisation of Firefly
luciferase activity to Renilla luciferase activity (pRL-TK refers to Renilla luciferase under the control of the thymidine kinase promoter). The data is
presented as the mean ± S.E., n = 5. Bim-LUC is activated significantly following NGF withdrawal (p = 0.001). Addition of the bim 3’ UTR significantly
decreases the basal promoter level of bim-LUC (p = 0.003). (C) The basal levels of bim-LUC and bim-LUC+3’UTR were normalised to 1 and the
induction factors of the two constructs were compared. Addition of the bim 3’ UTR significantly increases the induction of bim-LUC following NGF
withdrawal (p = 0.018). (D) Sympathetic neurons were microinjected with bim-LUC at 10 ng/μl or bim-LUC+3’UTR at 14 ng/μl, along with pRL-TK
(5 ng/μl). The cells were maintained in medium containing NGF and either left untreated (-U0126) or treated with U0126 at 10 μM (+U0126) for 16
hours, after which time luciferase activity was measured. The data is presented as the mean ± S.E., n = 6. Bim-LUC+3’UTR is activated significantly
following inhibition of the MEK-ERK pathway by treatment with U0126 (p = 0.015). Bim-LUC is not activated significantly following treatment with
U0126. (E) The basal levels of bim-LUC and bim-LUC+3’UTR were normalised to 1 and the induction factors of the two constructs were compared.
Addition of the bim 3’ UTR significantly increases the induction of bim-LUC upon inhibition of the MEK-ERK pathway (p = 0.022).
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Inhibition of the MEK-ERK pathway does not alter bim
mRNA stability
Since the MEK-ERK-responsive elements are located
within the bim 3’ UTR, we decided to investigate whether
U0126 alters bim mRNA stability. We used actinomycin-D
to inhibit bim transcription and measured bim mRNA
levels over a time course with or without U0126 (Figure 4).
In the first set of experiments actinomycin-D (0.1 μg/ml)
and U0126 (10 μM) were added to the cells together at
time point 0, and then total RNA was isolated at time
point 0 hours to 16 hours, as 16 hours is the time point at
which the original effect of U0126 was observed (Figure
1E; 4A). The level of bim mRNA was analysed by q-PCR
relative to the level of the transcripts for the house-keeping
genes Hprt1 and Gapdh. Bim mRNA levels relative to
Hprt1 are shown (Figure 4), since both house-keeping
genes behaved in a similar way - neither was affected by
the addition of U0126 or actinomycin-D. Following the
addition of actinomycin-D, bim mRNA decayed over the
16-hour time course in the absence of U0126 (Figure 4).
The half-life of rat bim mRNA is between 2 and 4 hours in
NGF-maintained sympathetic neurons treated with actino-
mycin-D (Figure 4A, B). Importantly, the addition of
U0126 did not significantly increase the stability of the bim
mRNA over the 16 hour time course (Figure 4A). To be
sure that this was a representative result, we performed a
second experiment in which we pre-treated sympathetic
neurons with U0126 for 16 hours prior to the addition of
actinomycin-D (for +U0126 conditions) (Figure 4B, C).
This would therefore rule out the possibility that actinomy-
cin-D was interfering with the activity of U0126. However,
the same result was obtained with no significant difference
in the half life of the bim mRNA in sympathetic neurons
treated with or without U0126 (Figure 4B). This indicates
that U0126 does not increase bim mRNA levels by altering
mRNA stability, in sympathetic neurons.
As a further control, we included a time course q-PCR
experiment in which we compared cells treated with
U0126 and actinomycin-D to those treated with U0126
only (Figure 4D). We found that bim mRNA levels
increased over the 16 hour time course and were signifi-
cantly higher, 3.3 fold, at 16 hours following treatment
with U0126 compared to time point 0, and that treat-
ment with actinomycin-D abolished this up-regulation
(Figure 4D). Furthermore, this data corroborates our
initial finding that treatment with U0126 for 16 hours
significantly elevates the level of bim mRNA in sympa-
thetic neurons (Figure 1E,4D).
The MEK1/2-ERK1/2 pathway negatively regulates bim
mRNA expression in sympathetic neurons
To investigate which of the MEK-ERK signalling path-
ways, MEK1/2-ERK1/2 or MEK5-ERK5, regulates bim
mRNA levels in sympathetic neurons we used a specific
MEK1/2 inhibitor, PD184352 [20]. To confirm that
phospho-ERK1/2 levels are reduced when sympathetic
neurons are treated with PD184352, immunoblots were
performed with extracts from sympathetic neurons
either maintained in NGF-containing medium or treated
with increasing concentrations of PD184352 in the pre-
sence of NGF (Figure 5A). Treatment of sympathetic
neurons with PD184352 at 2 μM strongly reduced the
phosphorylation of ERK1 and ERK2, whereas total ERK
protein levels were not altered (Figure 5A). To ensure
that PD184352 specifically inhibits MEK1/2, and does
not interfere with MEK5-ERK5 signalling in sympathetic
neurons, we repeated immunoblots on the PD184352-
treated samples (including a set of extracts prepared
from cells withdrawn from NGF for 16 hours) with anti-
bodies that detect phospho-ERK5 and ERK5 (Figure 5B).
NGF withdrawal reduced phosphorylation of ERK5 and,
as expected treatment of sympathetic neurons with
PD184352 at 2 μM in the presence of NGF did not
affect the phosphorylation of ERK5 and total ERK 5
levels were not altered either (Figure 5B).
We then performed q-PCR, as for Figure 1E, including
cDNA prepared from sympathetic neurons treated with
PD184352 at 2 μM in the presence of NGF for 16 hours
(Figure 5C). The level of bim mRNA was analysed rela-
tive to the level of the transcripts for the house-keeping
genes Hprt1 and Gapdh (Bim mRNA levels relative to
Hprt1 are shown). When sympathetic neurons were
treated with PD184352 there was a significant (2.9 fold)
increase in the level of bim mRNA (Figure 5C). This
was a similar fold induction to that observed following
treatment with U0126 (Figure 1E, 5C).
Next, we microinjected sympathetic neurons with bim-
LUC+3’UTR or bim-LUC and the cells were either main-
tained in medium containing NGF or treated with
PD184352 (2 μM) in the presence of NGF. After 16
hours, relative luciferase activity was determined (Figure
5D, E). Inhibition of the MEK1/2-ERK1/2 pathway with
PD184352 did not activate the bim-LUC construct, but
significantly activated the bim-LUC+3’UTR construct by
2.1 fold (Figure 5D, E). Taken together, this data con-
firms that the MEK1/2-ERK1/2 pathway represses bim
mRNA levels through the bim 3’UTR.
The MEK-ERK pathway contributes to cell survival in
sympathetic neurons
Finally, to determine whether inhibition of the prosurvi-
val MEK-ERK pathway is sufficient to induce cell death
in sympathetic neurons we studied the effect of U0126
on cell viability over 72 hours (Figure 6). Sympathetic
neurons were either maintained in the presence of NGF,
withdrawn from NGF or treated with U0126 (10 μM) in
the presence of NGF. The cells were then fixed and
stained with Hoechst dye to visualise the nuclei and the
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Figure 4 U0126 does not alter bim mRNA stability in sympathetic neurons. (A) Sympathetic neurons were treated with actinomycin-D at
0.1 μg/ml in the presence of NGF. The cells were either maintained in medium containing NGF (-U0126) or treated with U0126 at 10 μM in the
presence of NGF (+U0126). Actinomycin-D and U0126 were added to the cells together and then total RNA was isolated at time point 0 hours,
2 hours, 4 hours, 8 hours and 16 hours. The level of bim mRNA was analysed by q-PCR relative to the level of the mRNAs encoded by the
house-keeping genes Hprt1 and Gapdh. Bim mRNA levels relative to Hprt1 are shown here. The data is presented as the mean ± S.E., n = 5.
There is no significant difference in the stability of bim mRNA in sympathetic neurons treated with or without U0126 over 16 hours. (B)
Sympathetic neurons were treated as in (A) but with the following modification: U0126 was added to the cells for 16 hours prior to the addition
of actinomycin-D and U0126 together (for +U0126 conditions). Following addition of actinomycin-D, total RNA was isolated at time point 0
hours, 2 hours, 4 hours, 8 hours and 16 hours. The level of bim mRNA was analysed by q-PCR relative to the house-keeping genes Hprt1 and
Gapdh. Bim mRNA levels relative to Hprt1 are shown here. The data is presented as the mean ± S.E., n = 3. There is no significant difference in
the stability of bim mRNA in sympathetic neurons treated with or without U0126 over 16 hours. (C) Q-PCR data from (B) with raw bim mRNA
levels at timepoint 0 (+U0126 and -U0126 bim mRNA levels have not been normalised to 1). Treatment with U0126 for 16 hours elevates bim
mRNA levels significantly (p = 0.021), but does not significantly alter the half life of the bim mRNA. (D) Sympathetic neurons were either
maintained in medium containing NGF (-actinomycin-D) or treated with actinomycin-D (+actinomycin-D) at 0.1 μg/ml in the presence of NGF.
After 16 hours, the cells were treated with U0126 (together with actinomycin-D for +actinomycin-D conditions) and then total RNA was isolated
at time point 0 hours, 2 hours, 4 hours, 8 hours and 16 hours. The level of bim mRNA was analysed by q-PCR relative to Hprt1 and Gapdh. Bim
mRNA levels relative to Hprt1 are shown here. The data is presented as the mean ± S.E., n = 3. Treatment with U0126 for 16 hours, in the
absence of actinomycin-D, elevates bim mRNA levels significantly (p = 0.036).
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Figure 5 The MEK1/2-ERK1/2 pathway negatively regulates bim mRNA expression in sympathetic neurons. (A) Effect of PD184352 on
phosphorylation of ERK1/2 in sympathetic neurons. Immunoblots were performed with whole cell extracts from sympathetic neurons
maintained in the presence of NGF and left untreated or treated with PD184352 at 0.1, 1, 2 or 10 μM for 16 hours. Antibodies to detect total
ERK1/2 (Cell Signaling #9102) and phospho-ERK1/2 (Cell Signaling #9101) were used. (B) Effect of PD184352 on phosphorylation of ERK5 in
sympathetic neurons. Cells were treated as in (A), but including a set of extracts prepared from cells withdrawn from NGF for 16 hours, and
antibodies to detect total ERK5 (Cell Signaling #3372S) and phospho-ERK5 (Santa Cruz sc16564) were used. (C) Q-PCR data re-plotted from Figure
1E, but including the final data group where neurons were treated with PD184352 at 2 μM for 16 hours in the presence of NGF. The data is
presented as the mean ± S.E., n = 3. Endogenous bim mRNA levels increased significantly following NGF withdrawal (p = 0.015), treatment with
LY294002 or U0126, respectively (p = 0.014 and p = 0.0003). Treatment with PD184352 also induced a significant increase in the level of bim
mRNA (p = 0.05). (D) Sympathetic neurons were microinjected with bim-LUC at 10 ng/μl or bim-LUC+3’UTR at 14 ng/μl, along with pRL-TK
(5 ng/μl). The cells were maintained in medium containing NGF and either left untreated (-PD184352) or treated with PD184352 at 2 μM
(+PD184352) for 16 hours, after which time luciferase activity was measured. Relative luciferase activity was determined by normalisation of Firefly
luciferase activity to Renilla luciferase activity (pRL-TK refers to Renilla luciferase under the control of the thymidine kinase promoter). The data is
presented as the mean ± S.E., n = 4. Bim-LUC+3’UTR is activated significantly following inhibition of the MEK1/2-ERK1/2 pathway by treatment
with PD184352 (p = 0.005). Bim-LUC is not activated significantly following treatment with PD184352. (E) The basal levels of bim-LUC and bim-
LUC+3’UTR were normalised to 1 and the induction factors of the two constructs were compared. Addition of the bim 3’ UTR significantly
increases the induction of bim-LUC upon inhibition of the MEK1/2-ERK1/2 pathway (p = 0.009).
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number of cells with normal or pyknotic nuclei was
determined at time point 0, 24, 48 and 72 hours. Viable
cells retained a normal nuclear morphology and were not
pyknotic (Figure 6A, +NGF). At 72 hours, the percentage
of viable cells maintained in the presence of NGF was
over 95% (Figure 6B), whereas only 78% of the cells trea-
ted with U0126 had normal nuclei (Figure 6B). This data
indicates that the MEK-ERK pathway independently con-
tributes to cell survival in NGF-treated sympathetic
neurons.
Discussion
By using the MEK inhibitor U0126, we have demon-
strated that the prosurvival MEK-ERK pathway represses
bim mRNA levels in sympathetic neurons through the 3’
UTR. This effect is independent of PI3-K-Akt signalling
and represses bim transcription in the presence of NGF
(Figure 7).
After initially observing that the MEK-ERK pathway
negatively regulates bim mRNA expression in sympa-
thetic neurons, we generated a bim-LUC+3’UTR repor-
ter construct to investigate a potential role for the 3’
UTR in this mechanism. By microinjecting the bim-LUC
+3’UTR construct into sympathetic neurons, we loca-
lised the region responsive to MEK-ERK signalling to
the bim 3’ UTR. In addition, we found that the bim-
LUC+3’UTR construct is a useful tool for studying bim
regulation since it has a lower basal expression in the
presence of NGF and an increased induction following
NGF withdrawal. It may therefore be more representa-
tive of the endogenous bim gene, in comparison with
our previous bim-LUC reporter [8,9].
To further investigate this mechanism, we studied bim
mRNA stability following treatment with or without
U0126. Since we found no significant effect upon the
half life of the bim mRNA following treatment with
U0126, we concluded that MEK/ERK signalling does not
affect bim mRNA stability, and therefore may regulate
bim mRNA levels by a transcriptional mechanism.
Future studies will uncover potential cis-acting elements
located in the bim 3’ UTR, such as enhancers or silen-
cers that may bind DNA-binding proteins that regulate
transcription from the upstream bim promoter [21]. In
principle, these regulators might be activators that are
Figure 6 Effect of U0126 on cell viability in sympathetic neurons. Sympathetic neurons were either maintained in the presence of NGF,
withdrawn from NGF or treated with U0126 (10 μM) in the presence of NGF. The cells were fixed and stained with Hoechst dye and normal
and pyknotic nuclei were counted at time point 0, 24, 48 and 72 hours. (A) Example images of sympathetic neurons maintained in the presence
of NGF, treated with U0126 for 72 hours or withdrawn from NGF for 72 hours. Neurons were considered viable if they retained a normal nuclear
morphology. The white arrows indicate dead cells. The bar represents 10 μm. (B) Effect of U0126 on cell viability at 72 hours. The data is
presented as the mean ± S.E., n = 3. Treatment with U0126 (p = 0.040) and NGF withdrawal (p = 0.0004) significantly decreases the percentage
of viable neurons at 72 hours compared to the cells that were maintained in the presence of NGF.
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repressed by MEK-ERK signalling, or alternatively they
could be repressors that are activated by the MEK-ERK
pathway.
Recently, other groups have reported a role for the
bim 3’ UTR in modulating bim mRNA levels. Studies
with Baf-3 cells have revealed that bim mRNA is stabi-
lised when IL3 is limiting and this regulation occurs via
AU-rich elements found within the bim 3’ UTR [22].
Bim is also a target for regulation by miRNAs: the bim
3’ UTR contains sequences targeted by miR-17~92
microRNAs and the conditional knockout of miR-17~92
results in elevated Bim levels and an inhibition of B cell
development [23]. The bim mRNA can also be targeted
by miR-221 and miR-222, both of which are induced by
NGF-stimulation in PC12 cells and this is linked to the
MEK1/2-ERK1/2 pathway [24]. However, all of these
studies are associated with mRNA stability and not tran-
scription, so is unlikely that any of them account for the
mechanism we have described here.
In sympathetic neurons both the MEK1/2-ERK1/2 and
the MEK5-ERK5 signalling pathways are stimulated in
response to NGF and are activated downstream of Ras
[25], and U0126 inhibits both MEK1/2 and MEK5 [26].
A number of reports have described the importance of
MEK1/2-ERK1/2 signalling in the post-translational con-
trol of the Bim protein in different cell types [13-18].
The downstream events involved in MEK5-ERK5 signal-
ling in neurons are less well defined, but it has been
shown that ERK5 can play an important role in neuro-
trophin-mediated survival, and deletion of the erk5 gene
results in a significant increase in apoptosis in develop-
ing sympathetic neurons [27]. To determine which of
the ERK signalling pathways targets the 3’ UTR of the
bim gene, we used the specific MEK1/2-ERK1/2 inhibi-
tor PD184352 [20]. We found that this compound had
similar effects to U0126, indicating that this mechanism
of bim regulation largely depends on the MEK1/2-
ERK1/2 pathway in sympathetic neurons.
Figure 7 Model of the transcriptional regulation of bim expression by prosurvival signalling pathways in sympathetic neurons. The
MEK-ERK pathway negatively regulates bim expression at the level of transcription via the 3’ UTR by an unknown mechanism. PI3-K-Akt
signalling inhibits FOXO transcription factors which can bind to two conserved FOXO sites in the bim promoter [8,9]. Both prosurvival pathways
are activated following the binding of NGF to TrkA and act independently of each other to reduce bim mRNA levels.
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Finally, we showed that inhibition of the prosurvival
MEK-ERK pathway by treatment with U0126 was suffi-
cient to induce some neuronal death in the presence of
NGF. However, it should be noted that the effect was
modest compared to that observed following NGF
deprivation. This is probably because the PI3-K-Akt sur-
vival pathway is still active in cells treated with U0126
(Figure 1).
Conclusions
It is now evident that a number of complex regulatory
mechanisms are in place to constrain the expression
and the activity of the proapoptotic Bim protein. Thus,
using the well-characterised model of NGF-dependent
developing sympathetic neurons, we have identified an
additional mechanism by which bim mRNA levels are
regulated. We have shown that MEK-ERK signalling
represses bim mRNA levels through the bim 3’ UTR
(Figure 7). Since other reports investigating the function
of the bim 3’ UTR in modulating bim mRNA expression
have focused on the role of mRNA stability, it is likely
that the mechanism we have identified here has not yet
been studied in other cell types.
Methods
Plasmid constructs
The bim-LUC reporter construct consists of a 5.2 kb frag-
ment, containing the region immediately 5’ to the rat bim
initiator codon, sub-cloned into pGL3-Basic [8]. The bim-
LUC+3’UTR reporter construct was generated by PCR
amplification of the rat bim 3’ UTR from a restriction frag-
ment cloned from the PAC clone 215h9 (rat P1 artificial
chromosome (PAC) library RPC131, UK Human Genome
Mapping Project Resource Centre, Cambridge, UK). Initi-
ally, 3’ RACE was used to define the end point of the rat
bim 3’ UTR for subsequent cloning: RACE was performed
on rat lung poly A+ RNA using the Marathon cDNA
Amplification Kit (Clontech). The following primers were
then used to generate the 3’UTR in 2 fragments: Fragment
1, 5’-CTCACTAGTCAGGAGCTTCGTGCAG-3’ and 5’-
CTCCTACAAGGCACAAAACCCG-3’; fragment 2, 5’-CT
ATACGGATGTCCCTGTACTGTATC-3’ and 5’-CTCAC
TAGTCATGAGAGCTAGTCGCAA-3’. The 3’ UTR was
assembled in pBluescript SK (Stratagene) using a unique
BglII restriction site within the 4.2-kb region to link frag-
ments 1 and 2. The 3’ UTR was sub-cloned into bim-LUC,
using an XbaI restriction site downstream of the luciferase
reporter gene and upstream of the SV40 late poly (A)
signal.
Cell culture
Sympathetic neurons were isolated from the superior
cervical ganglia (SCG) of 1-day-old Sprague Dawley rats
and cultured as described previously [28]. Animal
experiments were performed according to the Animals
(Scientific Procedures) Act 1986 under a license
reviewed and approved by the Biological Services Unit
at University College London. Cells were maintained in
SCG medium supplemented with 2.5S NGF (Cedarlane)
at 50 ng/ml, and fluorodeoxyuridine and uridine (both
from Sigma-Aldrich) each at 20 μM. In NGF withdrawal
experiments, cells were rinsed twice with medium (with-
out NGF) and then re-fed with medium containing an
anti-NGF antibody at 100 ng/ml (Chemicon). The PI3-K
inhibitor LY294002 was used at a concentration of
50 μM and the MEK inhibitor U0126 at a concentration
of 10 μM (both from Promega). The MEK1/2 inhibitor
PD184352 was used at a concentration of 2 μM and was
kindly provided by Simon Cook (The Babraham Insti-
tute). The RNA synthesis inhibitor actinomycin-D was
used at a concentration of 0.1 μg/ml. When actinomy-
cin-D was used in conjunction with U0126, cells were
either pre-treated with U0126 (or actinomycin-D) for 16
hours prior to the addition of actinomycin-D (or U0126)
and then actinomycin-D and U0126 were added at the
same time (time point 0). LY294002, U0126 and
PD184352 were dissolved in DMSO and therefore equal
volumes of DMSO were added to the untreated cells as
a control.
Microinjection
Sympathetic neurons were cultured in vitro for 5-7 days
and then microinjected as described previously [3]. Dual
luciferase assays were carried out on injected cells using
the Dual Luciferase reporter assay system (Promega).
Cells were harvested for luciferase assays at 16 hours
following NGF withdrawal.
Real-time quantitative PCR (q-PCR)
RNA was isolated from sympathetic neurons and reverse
transcribed as described above. A bim specific primer and
probe set was designed using the PrimerExpress software
v2.0 (Applied Biosystems): bim forward primer 5’-CCAG
GCCTTCAACCATTATCTC-3’, bim reverse primer 5’-G
CGCAGATCTTCAGGTTCCT-3’ and bim probe 5’-TGC
AATGGCTTCCATAAGGCCAGTCTCA-3’. Glyceralde-
hyde-3-phosphate dehydrogenase (Gapdh) and Hypox-
anthine phosphoribosyltransferase 1 (Hprt1) were used as
house-keeping (control) genes (both from Applied Bio-
systems). Q-PCR data was analysed using the 2-ΔΔCT rela-
tive quantitation method [29].
Immunoblotting
Immunoblotting was carried out with whole cell extracts
from sympathetic neurons as described previously [30].
Proteins were separated on 7% or 12% SDS polyacryla-
mide gels. The following rabbit polyclonal primary anti-
bodies from Cell Signaling were used: ERK1/2 antibody
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(#9102), phospho-ERK1/2 (Thr 202/Tyr 204) (#9101),
ERK5 (#3372S), Akt antibody (#9272) and phospho-Akt
antibody (Ser 473) (#9271). The phospho-ERK5 (Thr
218/Tyr 220) goat polyclonal antibody was from Santa
Cruz (sc-16564), as was the mouse monoclonal phos-
pho-c-Jun (Ser 63) antibody (sc-822). The mouse mono-
clonal c-Jun antibody was from BD Biosciences
(#610327), the rabbit polyclonal Bim antibody was from
Chemicon (AB17003) and the rat monoclonal a-Tubulin
antibody was from AbD Serotec. For each immunoblot-
ting experiment, several repeats were carried out and
representative blots are shown.
Immunocytochemistry
Sympathetic neurons were fixed in 4% paraformalde-
hyde, permeabilised in 0.5% Triton-X-100, and stained
with Hoechst dye to visualise nuclear morphology.
Slides were viewed using a Zeiss Axioplan 2 fluores-
cence microscope using a Plan-Apochromat ×10 objec-
tive or ×63 oil objective. Cells were scored in a blinded
manner wherever possible.
Statistical analysis
In each set of experiments data is normalised to a con-
trol sample (for example, bim-LUC +NGF is set to 1).
For microinjection, the relative induction of a DNA con-
struct is calculated by dividing the relative luciferase
activity in the absence of NGF by the relative luciferase
activity in the presence of NGF. All data are presented
as the mean ± S.E. of multiple experiments.
The statistical significance of differences between means
was evaluated by performing an unpaired Student’s T-test
(for two-tailed distributions). To compare normalised data
to the control sample, that has no error associated to it
(for example, when comparing data to bim-LUC +NGF,
which is set to 1), the log10 values of the data were taken
and a one sample T-test was used (for two-tailed distribu-
tions). Statistical significance is presented as p-values: *** p
< 0.001, ** p < 0.01, * and p < 0.05.
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